Perturbing local steroidogenesis to improve breast cancer immunity
Single-cell RNA-seq · mouse · 20 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Mus musculus (mouse)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 20 samples: 6 conditions, mostly with about 5 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Perturbing local steroidogenesis to improve breast cancer immunityNature communications · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE255495_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1075107 and SRA study SRP489176. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 20 samples.
How we read this: 6 replicated groups read from 20 sample titles; they account for 20 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8073389 DCs_Ctrl1 DCs_Ctrl
- GSM8073390 DCs_GC1 DCs_GC
- GSM8073391 DCs_Ctrl2 DCs_Ctrl
- GSM8073392 DCs_GC2 DCs_GC
- GSM8073393 DCs_Ctrl3 DCs_Ctrl
- GSM8073394 DCs_GC3 DCs_GC
- GSM8073395 DCs_Ctrl4 DCs_Ctrl
- GSM8073396 DCs_GC4 DCs_GC
- GSM8073397 DCs_Ctrl5 DCs_Ctrl
- GSM8073398 DCs_GC5 DCs_GC
- GSM8073399 Cyp11a1KO_1 Cyp11a1KO
- GSM8073400 Cyp11a1KO_2 Cyp11a1KO
- GSM8073401 Cyp11a1KO_3 Cyp11a1KO
- GSM8073402 Ctrl_1 Ctrl
- GSM8073403 Ctrl_2 Ctrl
- GSM8073404 Ctrl_3 Ctrl
- GSM8073405 CD45+mCherry-_1 CD45+mCherry
- GSM8073406 CD45+mCherry-_2 CD45+mCherry
- GSM8073407 CD45+mCherry+_1 CD45+mCherry+
- GSM8073408 CD45+mCherry+_2 CD45+mCherry+
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares breast
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares breast
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing · shares breast
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares breast
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE296112 Augment proteasome inhibitor efficacy activates CD8+ T cell-mediated antitumor immunity in breast cancer 27 samples shares immunity, breast
- GSE274801 Differentiation fate of a stem-like CD4 T cell controls immunity to cancer 10 samples shares immunity
- GSE316054 Targeting the ADAR1 p150 isoform triggers tumor growth inhibition and antitumor immunity to overcome immunotherapy resistance 52 samples shares immunity
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.